D-Wave Quantum's Uphill Battle: Record Orders, a Revenue Collapse, and a $1.5 Billion Competitor IPO

D-Wave's Q1 revenue plunges 81% but record $33.4M bookings signal future growth. Stock down 54% from highs, in oversold territory. IPO filing by rival Quantinuum adds pressure.

The Quantum computing sector has a new heavyweight contender. Quantinuum, the Honeywell-backed quantum firm, filed with the SEC in mid-May to raise up to $1.5 billion in an IPO on the Nasdaq Global Select Market under the ticker QNT. In its S-1 filing, the company explicitly positioned itself alongside Alphabet, Amazon, IBM, and Microsoft while categorizing D-Wave, IonQ, and Rigetti as "less established" players. That direct competitive shot lands just as D-Wave Quantum's management begins a whirlwind tour of six Wall Street conferences to win back investor confidence.

The timing could hardly be more delicate. D-Wave's first-quarter 2026 results painted a stark picture: revenue plunged 81% year-over-year to just $6.3 million, while net losses widened to $18.4 million. Yet simultaneously, the company reported record bookings of $33.4 million — a nearly 2,000% surge over the same quarter last year. Two mega-deals underpin that figure: a $20 million Advantage2 system sale to Florida Atlantic University and a two-year, $10 million quantum-computing-as-a-service contract with a Fortune 100 enterprise. The disconnect between orders and recognized revenue is the central tension the company must address.

D-Wave's stock has felt the sting. At €17.48, the shares have shed 27% since January and 54% from an October 2025 high of €38.48. The relative strength index sits around 30, deep in oversold territory, while annualized volatility exceeds 110%. Friday alone brought an 8% drop. Still, the balance sheet offers a cushion: $588 million in cash and equivalents, virtually debt-free, and nearly double the cash pile of a year ago.

Management’s response is a packed schedule of investor outreach stretching from May 14 to June 10. Appearances are booked with Needham, J.P. Morgan (Boston, May 20), Canaccord Genuity (virtual quantum symposium, May 21), TD Cowen (New York, May 28), Baird, and Rosenblatt. The crescendo comes on June 1 with D-Wave’s first-ever Investor Day at the New York Stock Exchange, a three-hour session under the banner "The D-Wave Difference" that will lay out the technology roadmap, commercial progress, and path to profitability. On June 18, the company will host its Qubits Europe 2026 user conference in London.

Wall Street analysts remain constructive despite the turbulence. Mizuho trimmed its price target to $29 but kept an Outperform rating. Canaccord Genuity cut to $41 while reiterating Buy, and Wedbush affirmed its positive stance. The consensus target across all 13 covering firms stands at $35 — every single one recommends buying, none suggest selling. The message from the sell-side is that the booking momentum and cash position justify patience, provided D-Wave can convincingly translate its $33.4 million backlog into recurring revenue.

The first key test comes in Boston this week, where J.P. Morgan's conference offers management its earliest opportunity to address institutional investors directly since the Q1 miss. The June 1 Investor Day will be the decisive moment. Executives must show how the dual-platform strategy — combining annealing-based quantum computers with error-corrected gate-model systems — can bridge the gap between record orders and sustainable top-line growth. For the next quarter, the outlook remains cautious: management expects Q2 revenue of $6.3 million and Q3 revenue of $12.9 million, with a per-share loss of $0.08 in each period. Whether that trajectory accelerates hinges on how quickly those signed contracts convert to cash.